BIOMARIN PHARMACEUTICAL INC. |
Market Closed -
Other stock markets
|
After market 06:39:13 pm | |||
| 91.2 USD | -0.93% |
|
87.94 | -3.57% |
| Apr. 24 | Transcript : BioMarin Pharmaceutical Inc., Q1 2024 Earnings Call, Apr 24, 2024 | |
| Apr. 24 | BioMarin Pharmaceutical Q1 Non-GAAP EPS, Revenue Increase -- Shares Down After Hours | MT |
Chart calendar BioMarin Pharmaceutical Inc.
6056c0b4ee9f378b026c.kzRjKPwtdNdJdM-Fg4mN_6CaUxTwrnbx8K0lHSSKxLU.xkRTZapFEqYMHJvSwaTkyOr2Hl2j4SfAm-YQSnX69sTqbDVZn2cspB0hgg~711878e8d4232146083781e3222af704
Upcoming events on BioMarin Pharmaceutical Inc.
Past events on BioMarin Pharmaceutical Inc.
| 2024-04-24 04:30 pm | Q1 2024 Earnings Call |
| 2024-04-24 04:03 pm | Q1 2024 Earnings Release |
| 2024-03-15 10:30 am | American College of Medical Genetics Meeting - Poster #: P144 |
| 2024-03-15 10:30 am | American College of Medical Genetics Meeting - Poster #: P034 |
| 2024-03-14 01:30 pm | American College of Medical Genetics Meeting - Oral Session: O03 |
| 2024-03-14 10:30 am | American College of Medical Genetics Meeting - Poster #: P131 |
| 2024-03-14 10:30 am | American College of Medical Genetics Meeting - Poster #: P139 |
| 2024-03-14 10:30 am | American College of Medical Genetics Meeting - Poster #: P141 |
| 2024-03-14 10:30 am | American College of Medical Genetics Meeting - Poster #: P049 |
| 2024-03-12 01:35 pm | Barclays Global Healthcare Conference - Fireside Chat |
| 2024-03-11 | Jefferies Biotech on the Bay Summit |
| 2024-03-11 10:40 am | Leerink Partners Global Biopharma Conference - Fireside Chat |
| 2024-03-05 12:50 pm | TD Cowen Health Care Conference - Fireside Chat |
| 2024-02-22 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-22 04:03 pm | Q4 2023 Earnings Release |
| 2024-02-09 02:30 am | European Association for Haemophilia and Allied Disorders Congress - Oral No OR02 |
| 2024-02-09 02:30 am | European Association for Haemophilia and Allied Disorders Congress - Oral No OR10 |
| 2024-02-09 02:30 am | European Association for Haemophilia and Allied Disorders Congress - Oral No OR06 |
| 2024-02-07 12:30 pm | European Association for Haemophilia and Allied Disorders Congress - Poster No PO314 |
| 2024-02-07 12:30 pm | European Association for Haemophilia and Allied Disorders Congress - Poster No PO124 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 704 1 708 -0.22% | 1 860 1 851 0.53% | 1 846 1 843 0.2% | 2 096 2 096 -0.02% | 2 419 2 412 0.31% | 2 753 |
|
EBITDA Million USD | Released Forecast Spread | 4,84 1,92 151.64% | 68,4 106 -35.65% | 25,7 25,6 0.24% | 252 234 7.3% | 262 309 -14.96% | 485 |
|
EBIT Million USD | Released Forecast Spread | -100 -100,0 -0.47% | -36,8 -17,7 -107.38% | -82,3 -76,7 -7.4% | 150 158 -5.08% | 158 197 -19.91% | 572 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -94,8 -95,0 0.15% | -42,3 -26,1 -61.91% | -75,4 -75,1 -0.29% | 150 150 -0.48% | 189 230 -18.18% | 406 |
|
Net income Million USD | Released Forecast Spread | -23,8 -53,0 55.01% | 859 804 6.87% | -64,1 -67,7 5.3% | 142 131 8.47% | 168 190 -11.69% | 364 |
|
EPS USD | Released Forecast Spread | -0,13 -0,29 55.03% | 4,53 4,24 6.94% | -0,35 -0,37 5.12% | 0,75 0,68 9.89% | 0,87 0,98 -11.21% | 1,86 |
| Announcement Date | 26/02/20 | 25/02/21 | 23/02/22 | 27/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 450 442 1.68% | 519 509 1.97% | 534 522 2.27% | 505 516 -2.04% | 538 538 -0.13% | 596 570 4.56% | 595 595 0.01% | 581 608 -4.35% | 646 637 1.46% | 649 652 -0.46% | 668 | 693 | 742 | 724 |
|
EBITDA Million USD | Released Forecast Spread | 165 41,5 296.86% | 64,4 55,8 15.49% | 22,4 63,4 -64.72% | 0,05 60,6 -99.91% | 85,8 99,4 -13.71% | 51,3 | 41,1 40,5 1.55% | 116 90,7 27.64% | 100,0 | 78,0 | 94,3 | |||
|
EBIT Million USD | Released Forecast Spread | -65,9 -58,7 -12.22% | 137 45,1 204.31% | 39,2 30,7 27.55% | -2,42 10,7 -122.55% | -24,5 -4,85 -405.07% | 59,3 40,0 48.39% | 58,9 56,3 4.56% | 25,7 45,7 -43.88% | 14,2 50,9 -72.04% | 88,5 78,3 12.91% | 97,2 | 118 | 142 | 139 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -66,6 -63,4 -5.08% | 134 65,5 104.78% | 34,9 25,9 34.35% | -1,90 2,90 -165.68% | -17,6 -11,7 -49.75% | 56,8 28,8 96.93% | 70,8 42,3 67.56% | 41,7 52,7 -20.99% | 19,3 55,9 -65.45% | 106 72,1 46.43% | 86,9 | 96,3 | 117 | 138 |
|
Net income Million USD | Released Forecast Spread | -57,9 -57,2 -1.31% | 121 56,5 113.91% | 27,7 16,4 68.52% | -6,65 -0,74 -801.15% | -0,25 -12,2 97.95% | 50,9 29,1 74.76% | 56,0 42,5 31.76% | 40,4 42,4 -4.73% | 20,4 43,2 -52.79% | 88,7 61,9 43.19% | 78,3 | 99,0 | 113 | 113 |
|
EPS USD | Released Forecast Spread | -0,32 -0,34 5.01% | 0,63 0,24 157.44% | 0,15 0,09 66.57% | -0,04 0,00 -1008.03% | 0,00 -0,07 - | 0,27 0,15 76.85% | 0,29 0,21 37.87% | 0,21 0,22 -4.23% | 0,11 0,22 -50.46% | 0,46 0,33 40.75% | 0,40 | 0,51 | 0,57 | 0,52 |
| Announcement Date | 23/02/22 | 27/04/22 | 03/08/22 | 26/10/22 | 27/02/23 | 26/04/23 | 31/07/23 | 01/11/23 | 22/02/24 | 24/04/24 | - | - | - | - |
More events
Past sector events for BioMarin Pharmaceutical Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BMRN Stock
- Calendar BioMarin Pharmaceutical Inc.
